EN
HI

Eris Lifesciences Share price

ERIS

1595.8

0.60 (-0.04%)
NSE
BSE
Last updated on 20 Oct, 2025 | 11:46 IST
BUYSELL
Today's High

1598.90

Today's Low

1520.00

52 Week Low

1097.20

52 Week High

1910.00

The current prices are delayed, login to your account for live prices

Eris Lifesciences Share Key Metrics

Volume
1.30 L
Market Cap
21745.13 CR
LTQ@LTP
6@1595.80
ATP
1558.94
Var Margin
15.72 %
Circuit Range
1277.2-1915.6
Delivery %
72.06 %
Value
20.23 CR
ASM/GSM
No
Market Lot
1

Eris Lifesciences Fundamentals

View More
P/E Ratio

56.17

P/B Ratio

7.32

Div. Yield

0.46

Sector P/E

37.42

Sector P/B

3.53

Sec. Div. Yield

0.55

Eris Lifesciences Resistance and Support

Pivot 1750.27

Resistance

First Resistance

1775.54

Second Resistance

1815.27

Third Resistance

1840.54

Support

First Support

1710.54

Second Support

1685.27

Third Support

1645.54

Eris Lifesciences Futures & Options

Data Not Found

Eris Lifesciences Shareholding Pattern

View More
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2018-19
  • 2019-20
Total Promoters
Segment
Percent

Total Promoters

56.23%

Mutual Fund

11.13%

Insurance

0.01%

Foreign Institutional Investors

8.85%

Domestic Institutional Investors

0.67%

Retail

23.11%

Others

0%

Total Promoters
MAR '19
56.1%
JUN '19
56.23%
SEP '19
56.23%
DEC '19
56.23%

Eris Lifesciences Corporate Actions

DateAgenda
2025-08-05Quarterly Results
2025-05-19Audited Results
2025-02-07Interim Dividend
2025-02-04Quarterly Results
2024-10-25Quarterly Results
2024-08-02Quarterly Results

Eris Lifesciences News

Breakout Stocks: How to trade Vedanta, Swan Energy and Eris Lifesciences on Thursday

Dec 12 2024 09:01:54
Read More

About Eris Lifesciences

NSE : 21154  
BSE : 540596  
ISIN : INE406M01024  

The Company was incorporated as “Eris Lifescience Private Limited” on January 25 2007 as a private limited company under the Companies Act 1956 at Ahmedabad with a certificate of incorporation granted by the Registrar of Companies Gujarat Dadra and Nagar Haveli. Pursuant to a resolution of the Shareholders dated February 5 2007 the name of the Company was changed to “Eris Lifesciences Private Limited” and a fresh certificate of incorporation was issued by the Registrar of Companies Gujarat Dadra and Nagar Haveli on February 9 2007. Further pursuant to a conversion of the Company to a public limited company and as approved by the Shareholders through a resolution dated January 31 2017 the name was changed to “Eris Lifesciences Limited” and the RoC issued a fresh certificate of incorporation on February 2 2017.Major events and milestonesThe table below sets forth some of the major events in the history of the Company.2007-Incorporation of the Company-Launched “Eris” division focused on cardiology and diabetes segment2008-Launched “Nikkos” division focused on gastroenterology and orthopedics segment2009-Launched “Adura” division focused on cardiology and diabetes segment2011-Launched “Montana” division focused on gynecology and pediatrics segment2012-Launched “Inspira” division focused on cardiology segment2014-Launched “Victus” division focused on anti-diabetes segment-Set up Assam Facility by the Company2015-Launched “Eris 2” division focused on pain management segment2016-Acquired 40 registered and unregistered trademarks from Amay Pharmaceuticals Private Limited (now Aprica Pharmaceuticals Private Limited)-Acquired 100.00% of the outstanding equity shares of Aprica Healthcare Private Limited-Acquired 75.48% of the outstanding equity shares of Kinedex Healthcare Private Limited2017-Acquired the trademarks ‘UNION’ ‘REUNION’ and ‘BON UNION’Awards and Accreditations :2013-Awarded ‘Competitive Strategy Leadership’ award by Frost & Sullivan-Awarded ‘Emerging Companies Excellence’ award for scalability of business model and managing operational efficiencies by Business Today and Yes Bank

Read More

Eris Lifesciences Management

NamePosition
Mr. Amit Bakshi Chairperson & Managing Director
Mr. Krishnakumar Vaidyanathan COO & Executive Director
View More

Eris Lifesciences FAQs

The Buying Price of Eris Lifesciences share is 1595.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Eris Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Eris Lifesciences, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Eris Lifesciences shares is 56.17. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Eris Lifesciences shares is 7.32. Useful to assess the stock's value relative to its book value.

To assess Eris Lifesciences’s valuation compare Sector P/E, P/B which are 37.42 & 3.53 with sector averages, along with growth rates and financial metrics.

The Market Cap of Eris Lifesciences is 21745.13 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Eris Lifesciences share price is 1910.00 & 1097.20. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Eris Lifesciences belongs to the Healthcare sector.